Eli Lilly drug preserves lean mass in patients losing weight on Wegovy

statnews.com/2025/06/23/bimagrumab-eli-lilly-study-results-wegovy-lean-muscle-mass-fat-weight-loss

CHICAGO — An investigational therapy from Eli Lilly helped preserve lean mass and drive greater loss of fat in patients taking the popular obesity treatment Wegovy.
In a Phase 2 trial, patients taking the highest-dose combination of Wegovy and the drug, called bimagrumab, lost 22% of…

This story appeared on statnews.com, 2025-06-24 05:55:19.583000.
The Entire Business World on a Single Page. Free to Use →